Skip to content

R&Y ANAESTHESIA

Active
Private limited companyfounded 2024active for 1 yearRue Francisco Ferrer 9, 4460 Grâce-Hollogne, BelgiumKBO/BCE: BE 1016.774.784
Summary

R&Y ANAESTHESIA has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €53,447 and a net result of €50,947. Its solvency ranks better than 42% of 20,620 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is 0.4% (very low).

Overview

Activity
Specialist medical practice
NACE 86220
1 site
Size
≈ €170,000turnover 2025, estimated
Equity
€53,447
Profit
€50,947
Turnover estimated from the gross margin
Financial health
83 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.4%
Structure
2025 accounts 1 day early
Why 83raises riskLiquidity: current ratio 1.66Founded in 2024lowers riskSector: Human health activities (NACE 86)Figures for financial year 2025 (filed 30-07-2026)Show the evidence

Checked score

Score 2025
83 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 50% of its sector peers (NACE 86, micro)
Financial strength
Strong
Solvency 78
equity 53.0% of total assets
Liquidity 54
short-term debt 47.0%
Profitability 100
return on assets 50.5%
Bankruptcy probability, 12 months
0.4% Very low
0%0.5%1.5%4%10%≥ 25%

About 4 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,126 companies, NACE 86, micro)
Last 24 months 12-2025: 0.3%lowest value 01-2026: 0.3%● unchanged vs 12-2025lowest value 02-2026: 0.3%● unchanged vs 01-2026 03-2026: 0.3%● unchanged vs 02-2026 04-2026: 0.3%● unchanged vs 03-2026 05-2026: 0.3%● unchanged vs 04-2026 06-2026: 0.3%● unchanged vs 05-2026 07-2026: 0.4%▲ +0.1 percentage points vs 06-2026 08-2026: 0.4%● unchanged vs 07-2026 09-2026: 0.4%● unchanged vs 08-2026 10-2026: 0.4%● unchanged vs 09-2026highest value
Credit of up to €4,000 on 30-day terms is acceptable
Liquidity ample (current ratio 1.66, above the usual 1.5; short-term debt: 47% of total assets), and 47% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 42% on solvency, 28% on liquidity and 80% on profitability.

The bankruptcy probability was computed on 27-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
raises risk · Liquidity: current ratio 1.66
NBB · annual accounts
raises risk · Founded in 2024
Companies of this age fail more often than older ones; how much that weighs depends on the rest of its profile.
KBO
lowers risk · Figures for financial year 2025 (filed 30-07-2026)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-07-2026, 1 day ahead of the deadline.
NBB · 1 filing
Deviation from the deadline
2025
1 day early
← before the deadline after the deadline →
Searched, nothing found (1)
neutral · No strike-offs in the KBO publications
Searched since incorporation in 2024.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · micro…
  2. IncorporationAppointment: YENIDOGANAY Ranil (director) ·…

Key points

  • One director decidessole director in office 1 View
  • Total assets 2025first financial year filed €100,857 View
  • Active since 2024founded 29-11-2024 1 years View

By topic

Financials

Financial year
2025
Total assets
€100,857
Profit
€50,947
Solvency
53.0%
Go to Financials

Company details

Sites
1
Legal form
Private limited company
Activity
Specialist medical practiceNACE 86220
Founded
29-11-2024
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Key facts about R&Y ANAESTHESIA

What is the company number of R&Y ANAESTHESIA?
1016.774.784. In Belgium the VAT number is the company number with BE in front: BE 1016.774.784.
Where is R&Y ANAESTHESIA based?
The registered office is at Rue Francisco Ferrer 9, 4460 Grâce-Hollogne.Company details
What does R&Y ANAESTHESIA do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of R&Y ANAESTHESIA?
Private limited company (BV).
When was R&Y ANAESTHESIA founded?
On 29-11-2024.
Is R&Y ANAESTHESIA still active?
Yes, R&Y ANAESTHESIA is an active enterprise in the KBO register.
What is the turnover of R&Y ANAESTHESIA?
Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.Financials
Is R&Y ANAESTHESIA profitable?
In financial year 2025, R&Y ANAESTHESIA made a profit of €50,947.
Where can I find the annual accounts of R&Y ANAESTHESIA?
R&Y ANAESTHESIA filed 1 annual account with the National Bank of Belgium, for financial year 2025.

Companies related to R&Y ANAESTHESIA

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.